A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Summary

The study is a Phase 2a, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the pharmacodynamics (PD), safety and pharmacokinetics (PK) of multiple doses of SRSD107 in participants with coronary arterial disease (CAD) and/or peripheral arterial disease (PAD) with aspirin as background concomitant therapy.

Timeline

Start

2025-03-11

Primary completion

2027-12

Completion

2028-12

Drugs

Indications